Abstract. We report the complete sequence of the microtubule-associated protein MAP1B, deduced from a series of overlapping genomic and cDNA clones. The encoded protein has a predicted molecular mass of 255,534 D and contains two unusual sequences. The first is a highly basic region that includes multiple copies of a short motif of the form KKEE or KKF_~ that are repeated, but not at exact intervals. The second is a set of 12 imperfect repeats, each of 15 amino acids and each spaced by two amino acids. Subcloned fragments spanning these two distinctive regions were expressed as labeled polypeptides by translation in a cell-free system in vitro. These polypeptides were tested for their ability to copurify with unlabeled brain microtubules through successive cycles of polymerization and depolymerization. The peptide corresponding to the region containing the KKEE and KKE~ motifs cycled with brain microtubules, whereas the peptide corresponding to the set of 12 imperfect repeats did not. To define the microtubule binding domain in vivo, full-length and deletion constructs encoding MAP1B were assembled and introduced into cultured cells by transfection. The expression of transfected polypeptides was monitored by indirect immunofluorescence using anti-MAP1B-specific antisera. These experiments showed that the basic region containing the KKEE and KKF_~ motifs is responsible for the interaction between MAP1B and microtubules in vivo. This region bears no sequence relationship to the microtubule binding domains of kinesin, MAP2, or tau.
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M
ICROTUBULES prepared in vitro by successive cycles of assembly and disassembly consist largely of a-and/3-tubulin, together with a number of other proteins that are collectively defined as microtubuleassociated proteins (MAPs) ~ (for reviews, see 32, 35, 52) . Because neuronal cells are rich in microtubules, the best characterized MAPs are those from brain. Conventionally, these MAPs have been classified according to their molecular mass: the high molecular mass MAPs, MAFIA, MAPIB, MAFIC, and MAP2 (in the range 200-350 kD), and the low molecular mass MAPs, or tau proteins, a heterogeneous group of proteins in the range 35--40 kD (51) . MAP3 and MAP4 are less abundant than these; MAP3 is primarily expressed in astroglia and some neurons (21) , while MAP4 is expressed in glia, vascular, and some other tissues (37) . With the exception of MAP1C, which has been identified as cytoplasmic dynein (38, 49 ) the function of brain MAPs is essentially unknown, though many have been shown to promote microtuhule assembly upon addition to purified tubulin in vitro.
Among the high molecular mass MAPs, MAP1B (7) (which is referred to variously as MAP1.2 [16] , MAPI(X) [9] ,and MAP5 [40] ) differs from the others in its high abundance, its prominence both in association with microtubules 1. Abbreviation used in this paper: MAP, microtubule-associated protein.
and in soluble form, and the relative inefficiency with which it cycles with tubulin, particularly during the first cycle. Nonetheless, MAP1B is generally regarded as an authentic MAP because it does cocycle with purified tubulin and promote microtubule assembly in vitro (40) and because antisera specific for MAP1B (both polyclonal and monoclonal) identify characteristic microtubule networks in neuronal (and other) cells (6, 12) . MAP1B is expressed in the axons and dendrites of neurons, as well as in glia and other cells. Because it is especially prominent in axons during their initial outgrowth (40, 43) , it has been suggested that MAP1B plays a role in neurogenesis.
Several years ago, we isolated a set of cDNA clones encoding a portion of a MAP1 subspecies (28) . Subsequently, an antiserum (3d2) raised against a fusion protein derived from one of these clones was shown to uniquely recognize MAPIB on Western blots of brain microtubules and of total protein from PC12 cells (1) . The same antiserum also gives a staining pattern identical to that of other anti-MAPlB antisera on brain sections (A. Matus and N. J. Cowan, unpublished observations), thereby proving that our original set of cDNA clones were derived from MAFIB mRNAs. We have now obtained two genomic clones and further overlapping cDNA clones that together encode the entirety of MAPIB. Here we report the complete sequence of MAP1B, deduced from these clones. The encoded protein has a molecular mass of 255, 534 D and contains two unusual sequences. One is a set of 12 imperfect repeats that do not occur in any other sequenced protein, each 15 amino acids long, and spaced by 2 amino acids. The other is a highly basic region with many copies of the sequence KKEE and KK~, repeated but not at fixed intervals. We show that it is this latter region which is responsible for the binding of MAPlB to micrombules both in vitro and in vivo.
Materials and Methods

cDNA and Genomic Clones
eDNA from 5-d-old mouse brain mRNA was prepared as described (26) , except that half was ligated to Eco RI linkers (Boehringer Mannheim Biochemicals, Inc., Indianapolis, IN) and half to Xba I linkers, and each portion cloned into the vector ~Gem (Promega Biotec, Madison, WI). The resulting libraries were screened (4) as described in the text, using purified eDNA restriction fragments 32p-labeled by nick translation (41) . Hybridizing clones were subeloned into pUC, restriction-mapped, and, in some cases, sequenced. Sequencing of the complete set of overlapping clones on both strands was accomplished by subeloning bal31-generated fragments (27) into M13, and using the dideoxy chain terminator method (42) . Four overlapping genomic clones containing the 5' end of the MAPlB gene were obtained by screening a mouse genomic library in the EMBIA vector, ldndiy provided by P. WEustachio (New York Medical Center). The cosmid clone C (Fig. 1 ), including the 6-kb MAPIB exon, was isolated by screening a library (provided by S. Tonegawa, Massachusetts Institute of Technology) with done 141A (Fig. 1) .
Constructs for Translation, Fusion Proteins, and Transfection Experiments
Two constructs encompassing repeated sequences were made for in vitro transcription, translation, and cycling experiments as follows: (a) clone 72 was digested with Xho I, blunt-ended with the Klenow fragment of DNA polymerase I, cut with Bgl II, and the coding fragment (Fig. 1, 5 ' arrow) cloned into the transcription vector pGEM3 (Promega Biotec) cut with Hinc II and Barn HI; (b) clone 141A was digested with Pst I and Eco RI, and the purified fragment (Fig. 1, 3 ' arrow) cloned into pGEM3 cut with the same restriction enzymes. For both constructs, an in-frame translational start signal was provided by the pGEM vector. The insert from the first of these pGem clones, including the initiator AUG, was cloned into a pSV vector (34) for expression in cultured cells (Fig. 1, construct X) . In addition, constructs were made from the 5' and 3' end of the set of MAPIB cDNAs to place the translational start and stop signals: (a) the insert from clone 12X was subcloned into the Xba I site of pGEM1; and (b) the Sac I/Eco RI fragment was cloned into pGEM3 cut with Arc I, blunt ended with Klenow and then digested with Eco RI; this procedure supplied an AUG codon for translational initiation in frame with the MAPIB coding S~luence.
The full coding sequence of MAPIB was assembled, first by joining clones 12X and IR at an internal Ptim I site, then by digesting the resulting construct with Xho I and F, co RI, and finally by adding both the Xho I/Ssp I fragment from cosmid clone C and the Ssp I/F, co RI fragment from clone 166 in a three-way ligation. The clones and cloning sites are depicted in Fig.  1 . The full cloning region was subcloned into a pSV vector using a unique Sal I site in the 5' flanking pUC polylinker, and a unique Dra I site in the 3' untranslated region. Deleted versions were obtained by (a) joining a Msc I site to a Pvu I site blunt ended with I"4 DNA polymerase (Fig. 1, 1B-H); (b) deleting an '~l-kb Msc I fragment by self-ligating a gel purified fragment from a partial Msc I digest (Fig. 1, 1B-K) ; and (c) by joining the Xho I and Bg ]1 sites, by blunt ending each with the Klenow fragment of DNA polymerase I (Fig, 1, 1B-X) .
To raise an antiserum specific for the second set of repeats, a Pst I/Eco RI fragment (Fig. 1, 3 ' arrow) from clone 141A was subcloned into a pATH vector (29) that was used to express a fusion protein whose amino terminal part is Escherichia coil TrpE, and whose carboxyterminal part is derived from MAPIB. Fusion protein excised from SDS polyacrylamide gels was used to immunize rabbits. The resulting serum is called YXY; its specificity is demonstrated in Fig. 7 .
Transcription, Translation, and Microtubule Cycling Experiments
pGEM subclones were linearized at the 3' end and transcribed in vitro using SP6 polymerase as described (33) . The capped mRNAs were translated in rabbit reticulocyte lysate (Promnga Biotec) supplemented with either [35S]methionine or [3H]lysine. Translation products were resolved on SDS polyacrylamide gels, which were fluorographed, dried, and exposed to film. Micmtubule cycling experiments were performed as described (30) .
Hybrid Selection and Primer Extension
Clone 5X (Fig. I ) was used to select MAPIB-specific mRNA from total mouse brain RNA (100#gm/2.l-cm nitrocellulose filter) by methods described previously (17) . The selected RNA was used in a primer extension reaction containing an antisense oligonucleotide, 5'CCTGAGAGAAGT-GTTCCTY (corresponding to nucleotides 17-34 of the sequence shown in Fig. 4 ), 32p-end labeled with polynucleotide kinase. Reaction conditions and analysis of the extended product were as described (3) .
Transfection Experiments and Immunofluorescence
Hela cells were grown in DME supplemented with 5% FCS (Hydone Laboratories, Logan UT) in a 10% CO2 atmosphere; 3T3 cells were grown under the same conditions, except 10% FCS was used. Cells growing on glass coverslips were transfeeted with DNA by the procedure of Chen and Okayama (10) , and after 72 h fixed in one of three ways: (a) with paraformaidehyde (36); (b) with cold methanol for 6 min; or (c) with cold methanol following detergent extraction with 0.2% Triton X-100 in a microtubule stabilizing buffer (47) . lmmunofluorescence was performed using one of the twe rabbit anti-MAPIB antisera, 3d2 (1) or YXY (this paper). The regions of MAPIB to which these sera bind are shown in Fig. 1 . A mouse anti-c~-tubulin monoclonal antibody (Amersham Corp., Arlington Heights, IL) was used for double labeling; FITC-conjugated goat anti-rabbit and rhodamine conjugated goat anti-mouse second antibodies were from Boehringer Mannheim Biochemicals. All antibodies were used at a dilution of 1:500.
Results and Discussion
Isolation of Clones Encoding MAP1B
With a view to elucidating the structural and functional domains of MAP1B and its relationship to other MAPs, we first sequenced our original set of overlapping MAP1B-encoding cDNA clones. This analysis showed that the set of clones contains a long open reading frame of 5.4 kb, extending from the 5' end of the overlapping set to a location 1.5 kb from the 3' end. Because this open reading frame encodes a polypeptide of at most ,~198,000 D, we extended our collection of overlapping cloned cDNAs in the 5' direction by further "walking" experiments. To facilitate the search for overlapping clones, we constructed two mouse brain libraries using different linkers for cloning. These were first screened with a small fragment from the 5' end of our 5' most overlapped cDNAs (clone 72; reference 28), and twice more, each time with fragments obtained from the new set of clones. Representative examples from the complete set of overlapped cDNA clones are depicted in Fig. 1 . (Fig. 4 , nucleotides 6,303-7,333); lane 5, RNA from clone 137 linearized with Nae I (Fig. 4 , nucleotides 6,303-7,454). In lanes 3-5, the slowest migrating species results from initiation at an AUG triplet provided by the vector (see Materials and Methods), whereas the second prominent band presumably results from initiation at an internal AUG codon.
All attempts to extend this cloned set further in the 5' direction resulted in the isolation of numerous unrelated and nonoverlapping sequences that were presumed to be cloning artifacts generated by the unavoidable adventitious ligation of unrelated cDNA sequences during construction of the cDNA library, or by "hairpinning" of cDNA generated during the synthesis of the second strand. Sequence analysis of the overlapping 5' cDNA clones extended the long open reading frame to 7.5 kb. However, because this open reading frame extended to the extreme 5' end of our overlapped cDNAs, we cannot be certain whether the first AUG triplet indeed encodes the initiator methionine residue; it is possible that further upstream sequences encoding additional aminoterminal MAP1B residues might be unrepresented in our cDNA libraries. However, we did three further experiments which strongly suggest that translation of MAP1B does begin at the first AUG triplet found in our cDNA clones. Firstly, a fragment extending from the extreme 5' end of the overlapped cDNAs ( Fig. 1 ) was cloned into a vector
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AGAT CACCAAGACCC CAGAGGCAT CCACATACT CC T ATGA6ACCTCAGAC C6AT6C TACA 6260 before or after the putative stop codon. These linearized DNAs were then used as templates for in vitro mRNA synthesis, and the mRNA was translated in vitro in a rabbit reticulocyte lysate containing [35S]methionine. As shown in Fig. 2 , only the template cut 5' to the predicted stop codon (at Kpn I) yields a truncated product, thus confirming the existence of the stop codon at the position indicated in our MAP1B eDNA clones. Because of the large size of MAP1B and the total absence of any protein sequence data, we checked the putative open reading frame in two ways, in addition to verifying the start and stop codons as described above. First, we verified that the reading frame in each of our original Xgtll expression clones matched the predicted long open reading frame. Second, we made seven E. coli-trpE fusion proteins with various fragments derived from the set of cDNAs in the reading frames predicted by our sequence data. In each case, the size of the fusion protein was in good agreement with that calculated from our sequence data (data not shown). Two of these fusion proteins were used to raise antisera: 3d2 (reported previously [1] ) and YXY (see Fig. 1 ). These two fusion proteins were chosen because of their unusual amino acid sequences (see below). The sera generated using these fusion proteins are especially useful because they uniquely recognize two widely spaced and well defined regions of MAP1B. In particular, they are in all probability not against phosphorylated epitopes; antibodies to phosphorylated epitopes can produce confusing results, in part because the phosphorylation of MAPIB is dependent on developmental stage (43) , and also because some of these antibodies cross react with phosphorylated epitopes on the neurofilament and other proteins (2, 31) .
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Deduced Sequence of MAPIB
The sequence of our overlapping MAP1B cDNAs together with the deduced amino acid sequence of MAP1B is shown in Fig. 4 . The encoded protein is 2,463 amino acids long, with a molecular mass of 255,534 D. While this is smaller than its apparent size on SDS polyacrylamide gels, MAP1B (like tau, MAP2, and NF-M [18, 24, 25] ) is known to run anomalously large in such gels (12) . The predicted size of MAP1B is, however, ,,025 % larger than the calculated size of MAP2, which is consistent with their relative mobilities.
Two regions of repetitive amino acid sequence, each 'x,200 residues long, are evident in Fig. 4 . One is a highly basic region containing many sequences of the form KKEX, where X is almost always an acidic or hydrophobic residue. These repeated motifs do not fall into any strict pattern, although they are clustered in the central part of a region containing many basic amino acids. Indeed, the region from amino acids 589-787 has a calculated net charge of +30, and both the methods of Chou-Fasman (11) and Gamier et al. (15) predict that it folds into short, accessible hydrophilic c~-helices, although these predictions are notoriously unreliable (50) . The second repetitive region of MAP1B spans amino acids 1865-2070, and consists of 12 imperfect 15-amino acid-long repeats (Fig. 5) ; each repeat is separated by two nonconserved amino acids. This region is also quite hydrophilic, and is predicted to fall on a series of turns in the MAP1B molecule.
Recently, it has been discovered that MAP2 and tau have a highly similar carboxyterminal domain that contains three (or four [19, 20] ) 18-amino acid-long imperfect repeats (24, 30) . This domain has been shown to constitute the microtubule binding site of MAP2 and tau both in vitro (24, 30) and in vivo (S. A. Lewis, I. E. Ivanov, G. H. Lee, and N. J. Cowan, manuscript submitted for publication). However, the repeats in MAP2 and tau have no similarity to either the basic repeated motif of the 15-amino acid-long repeats in MAP1B, nor are there any regions of significant sequence homology between MAP1B and either tau or MAP2. Indeed, when the deduced amino acid sequence of MAP1B is compared with the PIR protein data base, no significant homol- Figure 6 . Translated protein corresponding to the first repeated motif in MAP1B cycles with microtubules in vitro. Capped RNAs transcribed from two regions (Fig. 1, arrows) were translated in a cell free system containing rH]lysine or [35S]methionine (see Materials and Methods). Translation products were cycled with microtubules, and at each stage, aliquots containing the same amount of protein (40 #gm) as judged by absorption at A2s0/A2~0 were analyzed on a 14% SDS-polyacrylamide gel. Lane 1, 3H-labeled protein derived from 5' subclone; lanes 2 and 3, 40 #g of microtubule protein after 1 and 2 additional cycles of assembly and disassembly in the presence of added 3H-labeled translation product. Lane 4, 35S-labeled protein derived from the 3' subclone; lanes 5 and 6, 40 #g of microtubule protein after 1 and 2 additional cycles of assembly and disassembly in the presence of added 3SS-labeled translation product. The times of exposure have been adjusted to compensate for the difference in specific activity between [3H]lysine and [35S]methionine in the cell-free system, the relative abundance of lysine and methionine residues in the respective peptides, and the relative fluorographic detection efficiency of the two isotopes.
ogies to other proteins are uncovered. However, the basic domain of MAP1B encompassing the KKEE and KKE~ repeated motifs shows some (probably fortuitous) sequence similarity to basic regions in other proteins, primarily to histones and other nuclear proteins but also to the highly charged tails of the neurofilament triplet proteins. This may account for the cross-reactivity of several anti-MAP1B antibodies with nuclear (12) or neurofilament (31) antigens.
The phosphorylation of MAP1B increases during neurite outgrowth, both in PCI2 cells induced to differentiate with nerve growth factor (1, 5, 14) and in neuroblastoma cells that generate neurites when serum is removed from the growth medium (13) . MAP1B is also found in phosphorylated form in developing axons in vivo (43) . These facts, together with the elevated levels of MAP1B protein found in developing axons (or neurites) in vivo and in vitro (14, 16, 43) , and the increased affinity of phosphorylated MAP1B for microtubules (13) , suggest that phosphorylated MAP1B plays a role in the cytoskeletal changes that accompany neurite extension. A casein kinase II type activity is implicated in MAPIB and t/-tubulin phosphorylation both in brain and in cultured differentiating neuroblastoma cells (13, 46) . Casein kinase II phosphorylates serine and threonine residues in sequences of the form ~, × ~ where X #: K, R; however, only those sequences that fall on/3 turns in a protein appear to be phosphorylated (39) . The primary recognition sequence for casein kinase H occurs 81 times in the MAP1B sequence; in 30 cases these sequences are predicted to form/3 turns by the Chou-Fasman and Gamier algorithms, and, in seven of these cases, turns are strongly predicted. These 30 potential phosphorylation sites are indicated in Fig. 4 ; nine are clustered in the region of MAP1B containing the 12 imperfect repeats.
The Microtubule Binding Domain of MAPIB
There exists within the MAP1B amino acid sequence two regions containing repeated motifs (discussed above). The fact that the microtubule binding regions of both MAP2 and tau contain repeated sequences (24, 30) , and that microtubules are themselves composed of repeating subunits suggested that one of these regions might constitute the microtubule binding domain. To test the ability of these domains to bind to microtubules, restriction fragments encoding regions spanning each set of repeats (Fig. 1, arrows) were subcloned into RNA transcription vectors; a translational start signal in the correct reading frame was in each case provided by the vectors. The resulting constructs were used as templates for the transcription of capped mRNA, and the transcription products used to direct protein synthesis in vitro in a rabbit reticulocyte lysate containing either [3H]lysine On the case of the first repeat region, which contains no methionine or cysteine residues) or [35S]methionine (in the case of the second repeat region). The translation products were added to two-cycle-purified, depolymerized bovine brain microtubules, which were then taken through two further cycles of polymerization and depolymerization. After each cycle, aliquots containing the same amount (40 #gm) of protein were removed and analyzed by SDS-PAGE, to see whether either labeled polypeptide could coassemble with the unlabeled carrier microtubules. The result of this experiment is shown in Fig. 6 . A labeled polypeptide derived from the first repeat region was observed to cycle with brain microtubules, though there is a significant loss (of ",,60%) of labeled polypeptide with each successive cycle; in contrast, a labeled polypeptide derived from the second repeat region completely failed to cycle. The relative inefficiency with which the labeled polypeptides from the first repeat region cycles with microtubules in vitro could result from competition with endogenous unlabeled MAP1B present in the microtubule preparations used in these experiments, or from the inherently poor cycling efficiency of MAP1B with microtubules in vitro (6), or a combination of both these factors. Nonetheless, these data suggest that the region containing the basic repeated sequence motifs is responsible for the cycling of MAP1B with microtubules during their purification.
To determine whether this domain is also responsible for MAP1B-microtubule interactions in vivo, a construct designed to express the entirety of MAP1B was made and transfected into cultured cells. To facilitate the assembly of a fulllength MAP1B coding region, we isolated a mouse genomic clone from a cosmid library containing a 6-kb exon (Fig. 1, clone C). After joining this exon to cDNAs derived from the 5' and 3' ends of the MAP1B transcript, the full coding sequence was inserted into a vector containing promotor and terminator sequences derived from SV40. The final construct was transfected into HeLa and 3T3 cells and the disposition of MAP1B in transfected cells was assayed by double label immunofluorescence, using either of the anti-MAP1B antisera 3d2 and YXY, described above, and a mouse antia-tubulin monoclonal antibody. The observed patterns of MAP1B staining were dependent on the fixation conditions: no MAPIB was observed bound to detergent extracted cytoskeletal preparations, but in cells fixed directly in methanol (in which case proteins are fixed and extracted simultaneously) MAP1B-decorated microtubules were observed (Fig.  7, a and b) . Notably, in cells fixed directly with paraformaldehyde, MAP1B filled the cytoplasm, obscuring the microtubule-bound MAP1B (data not shown). This implies that much or most MAPIB in transfected cells is in soluble form. Thus, in contrast to MAP2 (S. A. Lewis, I. E. Ivanov, G.-H. Lee, and N. J. Cowan, manuscript submitted for publication), MAP1B binds to microtubules weakly, and the equilibrium favors the unbound state since none remains bound to microtubules when the unbound portion is removed by detergent extraction. This is consistent with the behavior of MAP1B in brain (32) , and the poor cycling efficiency of MAP1B with microtubules in vitro (7) .
This assay for the binding of MAPIB to microtubules in vivo allowed us to define the microtubule binding domain by making constructs expressing deleted forms of MAP1B, and transfecting them into cultured cells. The results of these experiments are summarized in Fig. 1 ; representative immunofluorescence data are shown in Fig. 7 . Deletion of the 5' half of the MAPIB coding region (construct 1B-H) or of those sequences encoding amino acids 524-848 (construct 1B-K) results in the expression of truncated forms of MAP1B that have completely lost the capacity to bind to microtubules (e.g., Fig. 7, c and d) . Thus, the region of MAP1B containing the repeated KKEE and KKF_~ motifs is alone responsible for microtubule binding both in vitro and in vivo.
Two further constructs, X and 1B-X (Fig. 1) , show that the microtubule binding domain is divisible. The protein expressed from X includes only amino acids 646-732, whereas that expressed from IB-X contains all of MAP1B with the ex- ception of this region. Surprisingly, the protein expressed from each of these complementary constructs binds to microtubules with approximately the same efficiency (within the limits of our assay) as intact MAP1B. This implies that at least two subregions from the KKEE and KKE[, -containing region bind independently to microtubules. It therefore seems likely that MAP1B binds to at least two tubulin subunits in the polymer, and that this bridging of subunits is involved in nucleating microtubule polymerization and in stabilizing microtubules.
Conclusions
We have cloned and sequenced cDNAs spanning the entire coding region of the MAP1B gene, and shown that a basic region of the MAP1B protein, containing many repeats of the form KKEE or KKFA, is the MAP1B-microtubule binding domain. This was accomplished experimentally in vitro by cycling translated fragments with microtubules, and in vivo, by transfecting constructs expressing full-length and deleted forms of MAP1B into cultured cells. The MAP1B binding domain is completely unrelated to the highly similar microtubule-binding domains of MAP2 and tau, although like those domains, it has a net positive charge and contains repeated elements. Thus, in common with MAP2 and tau (44, 45) MAP1B probably interacts ionically with the negatively charged carboxyterminal portion of c~-and/or B-tubulin, though it has not been shown whether these molecules compete for the identical site on microtubules. The binding of MAP1B to microtubules is weak compared with MAP2, and unlike MAP2 (S. A. Lewis, I. E. Ivanov, G.-H. Lee, and N. J. Cowan, manuscript submitted for publication) expression of high levels of MAPIB in cultured cells does not result in any obvious cytoskeletal changes (Fig. 7, a and b) . However, MAP1B has two light chains that also associate with MAP1A (22, 23, 43); these and/or other coexpressed proteins may alter the properties of MAP1B.
The data presented here for MAP1B, together with that reported previously for MAP2 and tau (19, 20, 24, 30 ) and for kinesin (53), define three structurally unrelated kinds of microtubule binding domains. These differences must in some way reflect the different functions served by the interaction of each MAP with microtubules. For example, kinesin, which acts as a motor for anterograde transport along microtubules (8, 48), would be expected to have completely different binding properties from MAP2, which crosslinks and stabilizes microtubules in dendrites (S. A. Lewis, I. E. Ivanov, G.-H. lee, and N. J. Cowan, manuscript submitted for publication). Therefore, it is not surprising that their binding domains are completely dissimilar. It seems probable that each of these three binding domains is representative of a separate family of functionally related microtubule-associated proteins.
